Literature DB >> 8977552

Surgical treatment of malignant melanoma.

C P Karakousis1.   

Abstract

The surgical treatment of the primary melanoma site has been made more rational through correlations of rates of local control with various margins of resection in the context of the dominant prognostic indicator for localized melanoma, the thickness of the primary lesion. It is now known that for lesions less than 1 mm in thickness, a 1-cm margin is satisfactory. For lesions 1 to 4 mm thick, a 2-cm margin is adequate according to the results of a multi-institutional, randomized, surgical trial. Lesions thicker than 4 mm should be treated with a margin larger than 2 cm where the anatomy permits, although the main concern for these lesions is their high propensity for distant dissemination. Elective dissection has not been shown to alter survival significantly in prospective randomized trials. Surgical treatment of distant metastases is indicated for the palliation of a symptomatic lesion, for example, solitary brain metastasis or gastrointestinal metastases.

Entities:  

Mesh:

Year:  1996        PMID: 8977552     DOI: 10.1016/s0039-6109(05)70516-8

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

Review 1.  Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.

Authors:  Philip I Haigh; L Andrew DiFronzo; David R McCready
Journal:  Can J Surg       Date:  2003-12       Impact factor: 2.089

2.  Pancreaticoduodenectomy for metastatic tumors to the periampullary region.

Authors:  H Medina-Franco; N B Halpern; J S Aldrete
Journal:  J Gastrointest Surg       Date:  1999 Mar-Apr       Impact factor: 3.267

3.  Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

Authors:  Paolo A Ascierto; Michael Atkins; Carlo Bifulco; Gerardo Botti; Alistair Cochran; Michael Davies; Sandra Demaria; Reinhard Dummer; Soldano Ferrone; Silvia Formenti; Thomas F Gajewski; Claus Garbe; Samir Khleif; Rolf Kiessling; Roger Lo; Paul Lorigan; Grant Mc Arthur; Giuseppe Masucci; Ignacio Melero; Martin Mihm; Giuseppe Palmieri; Giorgio Parmiani; Igor Puzanov; Pedro Romero; Bastian Schilling; Barbara Seliger; David Stroncek; Janis Taube; Sara Tomei; Hassane M Zarour; Alessandro Testori; Ena Wang; Jérôme Galon; Gennaro Ciliberto; Nicola Mozzillo; Francesco M Marincola; Magdalena Thurin
Journal:  J Transl Med       Date:  2015-11-30       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.